Old Web
English
Sign In
Acemap
>
authorDetail
>
Mingyue Liu
Mingyue Liu
Shenyang Pharmaceutical University
PI3K/AKT/mTOR pathway
Cancer research
In vivo
Breast cancer
Chemistry
4
Papers
15
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Dual blocking of PI3K and mTOR signaling by DHW-221, a novel benzimidazole derivative, exerts antitumor activity in human non-small cell lung cancer.
2021
Clinical and translational medicine
Xiaochun Qin
Mingyue Liu
Yuting Wu
Shu Wang
Siheng Lian
Hui Jia
Qiong Wu
Huai-Wei Ding
Qingchun Zhao
Show All
Source
Cite
Save
Citations (0)
Cimigenoside functions as a novel γ-secretase inhibitor and inhibits the proliferation or metastasis of human breast cancer cells by γ-secretase/Notch axis
2021
Pharmacological Research
Hui Jia
Mingyue Liu
Xinying Wang
Qiyu Jiang
Shu Wang
Ramesh Kumar Santhanam
Chongning Lv
Qingchun Zhao
Jincai Lu
Show All
Source
Cite
Save
Citations (6)
Which Is the Most Appropriate PI3K Inhibitor for Breast Cancer Patients with or without PIK3CA Status Mutant? A Systematic Review and Network Meta-Analysis
2020
BioMed Research International
Shu Wang
Mingyue Liu
Siheng Lian
Naiming Liu
Guibin Zhang
Qingchun Zhao
Yingshi Zhang
Lingyan Jian
Show All
Source
Cite
Save
Citations (2)
Alpinia oxyphylla oil induces apoptosis of hepatocellular carcinoma cells via PI3K/Akt pathway in vitro and in vivo
2019
Biomedicine & Pharmacotherapy
Fuhai Hui
Xiaochun Qin
Qiao Zhang
Ruolan Li
Mingyue Liu
Tianshu Ren
Mingyi Zhao
Qingchun Zhao
Show All
Source
Cite
Save
Citations (7)
1